Literature DB >> 15863837

Differential regulation and properties of angiopoietin-like proteins 3 and 4.

Hongfei Ge1, Ji-Young Cha, Harini Gopal, Christopher Harp, Xinxin Yu, Joyce J Repa, Cai Li.   

Abstract

Angiopoietin-like protein 3 and 4 (Angptl3 and Angptl4) are two members of the angiopoietin-like family of proteins. These two closely related proteins have been reported to similarly affect lipid metabolism through their capacity to inhibit lipoprotein lipase. We undertook a series of studies to compare the structure, function, and regulation of Angptl3 and Angptl4. Previously, we reported that Angptl4 exists as variable-sized oligomers that contain intermolecular disulfide bonds. We now have evidence that although there are no intermolecular disulfide bonds evident in Angptl3, higher molecular weight forms do exist. In addition, Angptl4 exhibits a widespread distribution of tissue expression, while Angptl3 is exclusively expressed in the liver. Treatments with various ligands of nuclear receptors reveal that Angptl3 is a target gene of liver X receptor, while Angptl4 expression is activated by ligands of all peroxisome proliferator-activated receptors. Expression of Angptl4 in adipose tissue and liver is induced by fasting, while Angptl3 expression is not appreciably affected by nutritional status. We suggest that the differential regulation of Angptl3 and Angptl4 by sites of expression, nutritional status, and ligands of nuclear receptors may confer unique roles of each in lipoprotein metabolism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15863837     DOI: 10.1194/jlr.M500005-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   6.676


  61 in total

1.  Fatty acids bind tightly to the N-terminal domain of angiopoietin-like protein 4 and modulate its interaction with lipoprotein lipase.

Authors:  Terje Robal; Mikael Larsson; Miina Martin; Gunilla Olivecrona; Aivar Lookene
Journal:  J Biol Chem       Date:  2012-07-07       Impact factor: 5.157

Review 2.  ANGPTL4 in Metabolic and Cardiovascular Disease.

Authors:  Binod Aryal; Nathan L Price; Yajaira Suarez; Carlos Fernández-Hernando
Journal:  Trends Mol Med       Date:  2019-06-21       Impact factor: 11.951

3.  Enterococcus faecalis from newborn babies regulate endogenous PPARgamma activity and IL-10 levels in colonic epithelial cells.

Authors:  Alexandra Are; Linda Aronsson; Shugui Wang; Gediminas Greicius; Yuan Kun Lee; Jan-Ake Gustafsson; Sven Pettersson; Velmurugesan Arulampalam
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-30       Impact factor: 11.205

4.  Metreleptin therapy lowers plasma angiopoietin-like protein 3 in patients with generalized lipodystrophy.

Authors:  Ranganath Muniyappa; Brent S Abel; Asha Asthana; Mary F Walter; Elaine K Cochran; Alan T Remaley; Monica C Skarulis; Phillip Gorden; Rebecca J Brown
Journal:  J Clin Lipidol       Date:  2017-02-24       Impact factor: 4.766

Review 5.  ANGPLT3 in cardio-metabolic disorders.

Authors:  Xin Su
Journal:  Mol Biol Rep       Date:  2021-03-06       Impact factor: 2.316

6.  Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans.

Authors:  Stefano Romeo; Wu Yin; Julia Kozlitina; Len A Pennacchio; Eric Boerwinkle; Helen H Hobbs; Jonathan C Cohen
Journal:  J Clin Invest       Date:  2008-12-15       Impact factor: 14.808

7.  An ANGPTL4-ceramide-protein kinase Cζ axis mediates chronic glucocorticoid exposure-induced hepatic steatosis and hypertriglyceridemia in mice.

Authors:  Tzu-Chieh Chen; Rebecca A Lee; Sam L Tsai; Deepthi Kanamaluru; Nora E Gray; Nicholas Yiv; Rachel T Cheang; Jenna H Tan; Justin Y Lee; Mark D Fitch; Marc K Hellerstein; Jen-Chywan Wang
Journal:  J Biol Chem       Date:  2019-05-03       Impact factor: 5.157

8.  Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis.

Authors:  Yan Wang; Fabiana Quagliarini; Viktoria Gusarova; Jesper Gromada; David M Valenzuela; Jonathan C Cohen; Helen H Hobbs
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

9.  Histone deacetylase 3 depletion in osteo/chondroprogenitor cells decreases bone density and increases marrow fat.

Authors:  David F Razidlo; Tiffany J Whitney; Michelle E Casper; Meghan E McGee-Lawrence; Bridget A Stensgard; Xiaodong Li; Frank J Secreto; Sarah K Knutson; Scott W Hiebert; Jennifer J Westendorf
Journal:  PLoS One       Date:  2010-07-09       Impact factor: 3.240

10.  Atypical angiopoietin-like protein that regulates ANGPTL3.

Authors:  Fabiana Quagliarini; Yan Wang; Julia Kozlitina; Nick V Grishin; Rhonda Hyde; Eric Boerwinkle; David M Valenzuela; Andrew J Murphy; Jonathan C Cohen; Helen H Hobbs
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.